National Health Investors (NYSE:NHI) Research Coverage Started at Huntington

Huntington initiated coverage on shares of National Health Investors (NYSE:NHI) in a research report report published on Thursday morning, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $79.00 target price on the real estate investment trust’s stock.

A number of other equities analysts have also issued reports on the stock. Wells Fargo & Company dropped their target price on shares of National Health Investors from $79.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Tuesday, September 1st. Weiss Ratings downgraded shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. National Bank Financial set a $79.00 price objective on shares of National Health Investors in a report on Wednesday. Deutsche Bank Aktiengesellschaft cut their price objective on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Thursday, June 25th. Finally, Truist Financial reduced their target price on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, September 2nd. Six analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $82.25.

National Health Investors Price Performance

NYSE NHI opened at $70.43 on Thursday. The stock has a 50-day simple moving average of $74.73 and a 200 day simple moving average of $77.55. National Health Investors has a twelve month low of $67.94 and a twelve month high of $91.38. The stock has a market capitalization of $3.46 billion, a PE ratio of 20.36, a P/E/G ratio of 3.75 and a beta of 0.52. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78.

National Health Investors (NYSE:NHI) last released its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The firm had revenue of $121.32 million for the quarter. During the same period last year, the business earned $1.22 EPS. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Research analysts anticipate that National Health Investors will post 4.76 EPS for the current year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s dividend payout ratio is presently 106.36%.

Insider Buying and Selling

In other National Health Investors news, Director Robert A. Mccabe, Jr. purchased 890 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the purchase, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This represents a 2.06% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On National Health Investors

Hedge funds have recently made changes to their positions in the business. International Assets Investment Management LLC bought a new stake in National Health Investors in the fourth quarter valued at about $27,000. EverSource Wealth Advisors LLC lifted its stake in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares during the period. Garton & Associates Financial Advisors LLC bought a new position in National Health Investors during the fourth quarter worth about $33,000. Allworth Financial LP bought a new position in National Health Investors during the second quarter worth about $42,000. Finally, Advisory Services Network LLC acquired a new stake in National Health Investors during the third quarter valued at approximately $65,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE:NHI) is a real estate investment trust that owns and finances healthcare real estate. The company focuses primarily on properties serving older adults and patients requiring specialized care, including independent living, assisted living, memory care, skilled nursing and continuing care retirement communities.

NHI generally leases its properties to healthcare and senior-living operators under long-term agreements, including primarily triple-net leases, under which tenants are typically responsible for property-level operating expenses, maintenance and taxes.